Form 4: Doximity Director Sells Shares Under Pre-Arranged Trading Plan

A Doximity, Inc. director executed a pre-scheduled sale of 2,000 Class A Common Stock shares for $57.09 each, following the conversion of Class B shares.

Summary

• Kira Scherer Wampler, a Director of Doximity, Inc. (DOCS), engaged in a pre-scheduled transaction on August 1, 2025.
• The transaction involved the conversion of 2,000 shares of Class B Common Stock into an equal number of Class A Common Stock.
• Immediately following the conversion, 2,000 shares of Class A Common Stock were sold at a price of $57.09 per share.
• This sale was conducted automatically under a Rule 10b5-1 trading plan adopted by the director on November 12, 2024.
• After these transactions, the director directly holds 16,618 shares of Class A Common Stock.
• The director also exercised 2,000 stock options (right to buy) at an exercise price of $1.54, which were granted on June 10, 2020, and vested in 36 equal monthly installments after March 27, 2020.
• Following the option exercise, the director beneficially owns 470,700 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The transaction involves a director selling shares, which can sometimes be viewed negatively. However, the sale was executed under a pre-arranged Rule 10b5-1 trading plan, which mitigates concerns about opportunistic selling and indicates a planned, rather than reactive, disposition of shares. The director also continues to hold a substantial number of shares and options.

Positives

• The transaction was executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent sale rather than a reactive one.
• The director continues to hold a significant number of shares (16,618 Class A shares) and substantial derivative securities (470,700 stock options), indicating continued alignment with shareholder interests.

Negatives

• A director's sale of shares, even if pre-planned, reduces their direct equity stake in the company.

Risks

• No specific risks are detailed in this Form 4 filing beyond the inherent market risks associated with stock transactions.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.

Related Party Transactions

• The reported transaction is a related party transaction as it involves a director of the company selling shares.

Stakeholder Impact

• Shareholders: The sale by a director could be perceived as a slight negative due to reduced insider ownership, but the 10b5-1 plan context suggests it's a routine liquidity event.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

The filing reports a routine, pre-scheduled insider sale by a director under a 10b5-1 plan. While it reduces the director's direct shareholding, the planned nature of the transaction and the director's continued significant holdings (including options) suggest it's not a signal of negative sentiment towards the company's future prospects. Therefore, it does not warrant a change in investment stance based solely on this filing.

Keywords

Doximity, DOCS, Insider Trading, Form 4, Stock Sale, Director, Rule 10b5-1, Class A Common Stock, Class B Common Stock, Stock Option, Kira Scherer Wampler